Effect of IMOD™ on the inflammatory process after acute ischemic stroke: a randomized clinical trial

作者: Mehdi Farhoudi , Mahdi Najafi-Nesheli , Mazyar Hashemilar , Ata Mahmoodpoor , Ehsan Sharifipour

DOI: 10.1186/2008-2231-21-26

关键词:

摘要: Considering the role of inflammation in acute cerebrovascular accidents, anti-inflammatory treatment has been considered as an option diseases. Regarding properties Setarud (IMOD™) immune regulation, aim present study was to evaluate this medication treating patients with ischemic stroke. In randomized clinical trial, 99 their first ever stroke were divided into two groups IMOD™ (n = 49) and control (n = 50). The group underwent routine intervention plus daily intermittent infusion (250mg on day then 375mg DW5% serum during a 30-minute period for 7 days). levels inflammatory markers evaluated (baseline) 4th 7th days. Data analyzed results compared. 58 males (58.6%) 41 females (41.4%) mean age 67.00 ± 8.82 years, who had attack, enrolled trial. Treatment showed decreasing trend IL-6 compared (p = 0.04). addition, resulted increasing hsCRP after days (p = 0.02). There insignificant decrease TNF-α IL-1 group. prominent cerebral damage, it appears that improves profile. Therefore, (Setarud) might be therapeutic However, future studies are necessary its long-term efficacy.

参考文章(45)
Farzaneh Dehghanian, Majid Asadi-Shekaari, Nasser Zangiabadi, Farzaneh Vafaee, Fatemeh Mehdi Pour, Hossein Karimi Afshar, Neuroprotective effects of the immunomodulatory drug Setarud on cerebral ischemia in male rats Neural Regeneration Research. ,vol. 7, pp. 2085- 2091 ,(2012) , 10.3969/J.ISSN.1673-5374.2012.27.001
A Mohammadirad, A Dehnadi-Moghadam, A Ahmadi, M Baeeri, M Mojtahedzadeh, M Abdollahi, A Najafi, A Mahmoodpoor, K Eslami, Examination of Setarud (IMOD™) in the management of patients with severe sepsis Tehran University of Medical Sciences. ,vol. 18, pp. 23- 28 ,(2010)
M Abdollahi, R Abrishami, M R Khoshayand, K Eslami, M T Beigmohammadi, M Kanani, A Mahmoodpour, M R Mirjalili, A Ahmadi, H Hamishehkar, M Baeeri, M Mojtahedzadeh, IDENTIFICATION OF ENHANCED CYTOKINE GENERATION FOLLOWING SEPSIS. DREAM OF MAGIC BULLET FOR MORTALITY PREDICTION AND THERAPEUTIC EVALUATION DARU. ,vol. 18, pp. 155- 162 ,(2010)
Nazeeha Hasan, Peter McColgan, Paul Bentley, Robert J. Edwards, Pankaj Sharma, Towards the identification of blood biomarkers for acute stroke in humans: a comprehensive systematic review British Journal of Clinical Pharmacology. ,vol. 74, pp. 230- 240 ,(2012) , 10.1111/J.1365-2125.2012.04212.X
J. Montaner, P. Chacón, J. Krupinski, F. Rubio, M. Millán, C. A. Molina, P. Hereu, M. Quintana, J. Alvarez-Sabín, Simvastatin in the acute phase of ischemic stroke: a safety and efficacy pilot trial. European Journal of Neurology. ,vol. 15, pp. 82- 90 ,(2007) , 10.1111/J.1468-1331.2007.02015.X
K. Rajeshwar, Subhash Kaul, Amal Al-Hazzani, M. Sai Babu, N. Balakrishna, Vandana Sharma, A. Jyothy, Anjana Munshi, C-reactive protein and nitric oxide levels in ischemic stroke and its subtypes: correlation with clinical outcome. Inflammation. ,vol. 35, pp. 978- 984 ,(2012) , 10.1007/S10753-011-9401-X
Guillermo R. Schinella, Rosa-María Giner, MaríA Del Carmen Recio, Perla Mordujovich Buschiazzo, José-luis Ríos, Salvador MÁñez, Anti-inflammatory effects of South American Tanacetum vulgare. Journal of Pharmacy and Pharmacology. ,vol. 50, pp. 1069- 1074 ,(2011) , 10.1111/J.2042-7158.1998.TB06924.X
Seyed Sajad Mohseni-Salehi-Monfared, Ebad Habibollahzadeh, Hooman Sadeghi, Maryam Baeeri, Mohammad Abdollahi, Efficacy of Setarud (IMOD™), a novel electromagnetically-treated multi-herbal compound, in mouse immunogenic type-1 diabetes Archives of Medical Science. ,vol. 6, pp. 663- 669 ,(2010) , 10.5114/AOMS.2010.17078
Kate Lykke Lambertsen, Knut Biber, Bente Finsen, Inflammatory cytokines in experimental and human stroke Journal of Cerebral Blood Flow and Metabolism. ,vol. 32, pp. 1677- 1698 ,(2012) , 10.1038/JCBFM.2012.88